The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Fluoroquinolones: Action and Resistance
Abstract
Fluoroquinolones trap gyrase and topoisomerase IV on DNA as ternary complexes that block the movement of replication forks and transcription complexes. Studies with resistant mutants indicate that during complex formation quinolones bind to a surface alpha-helix of the GyrA and ParC proteins. Lethal action is a distinct event that is proposed to arise from release of DNA breaks from the ternary complexes. Many bacterial pathogens are exhibiting resistance due to alterations in drug permeability, drug efflux, gyrase-protecting proteins, and target topoisomerases. When selection of resistant mutants is described in terms of fluoroquinolone concentration, a threshold (mutant prevention concentration, MPC) can be defined for restricting the development of resistance. MPC varies among fluoroquinolones and pathogens; when combined with pharmacokinetics, MPC can be used to identify compounds least likely to enrich mutant subpopulations. Use of suboptimal doses and compounds erodes the efficacy of the class as a whole because resistance to one quinolone reduces susceptibility to others and/or increases the frequency at which resistance develops. When using fluoroquinolones in combination therapy, the development of resistance may be minimized by optimizing regimens for pharmacokinetic overlap.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Supercoiling of the DNA template during transcription.
Liu, L. F., & Wang, J. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7024 · Cited by 1,962
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Self-citationDNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Complete Genome Sequence of Treponema pallidum, the Syphilis Spirochete
Fraser, C. M., Norris, S. J., Weinstock, G. M., White, O., Sutton, G. G., Dodson, R., Gwinn, M., Hickey, E. K., Clayton, R., Ketchum, K. A., et al. (1998) · Science · doi:10.1126/science.281.5375.375 · Cited by 1,081
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
Evolution of high mutation rates in experimental populations of E. coli
Sniegowski, P. D., Gerrish, P. J., & Lenski, R. E. (1997) · Nature · doi:10.1038/42701 · Cited by 879
Structure and mechanism of DNA topoisomerase II
Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996) · Nature · doi:10.1038/379225a0 · Cited by 859
High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens
LeClerc, J. E., Li, B., Payne, W. L., & Cebula, T. A. (1996) · Science · doi:10.1126/science.274.5290.1208 · Cited by 817
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Topoisomerase II is a structural component of mitotic chromosome scaffolds.
Earnshaw, W. C., Halligan, B., Cooke, C. A., Heck, M. M., & Liu, L. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.5.1706 · Cited by 749
Transcription generates positively and negatively supercoiled domains in the template
Wu, H.-Y., Shyy, S., Wang, J. C., & Liu, L. F. (1988) · Cell · doi:10.1016/0092-8674(88)90163-8 · Cited by 743
Engberg, J., Aarestrup, F. M., Taylor, D. E., Gerner-Smidt, P., & Nachamkin, I. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0701.010104 · Cited by 696
New topoisomerase essential for chromosome segregation in E. coli
Kato, J.-I., Nishimura, Y., Imamura, R., Niki, H., Hiraga, S., & Suzuki, H. (1990) · Cell · doi:10.1016/0092-8674(90)90172-b · Cited by 566
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Crystal structure of an N-terminal fragment of the DNA gyrase B protein
Wigley, D. B., Davies, G. J., Dodson, E. J., Maxwell, A., & Dodson, G. (1991) · Nature · doi:10.1038/351624a0 · Cited by 533
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H., & Schentag, J. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.521 · Cited by 507
Takiff, H. E., Salazar, L., Guerrero, C., Philipp, W., Huang, W. M., Kreiswirth, B., Cole, S. T., Jacobs, W. R., & Telenti, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.773 · Cited by 480
Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6942-6949.1990 · Cited by 479
Crystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes
Dinardo, S., Voelkel, K. A., Sternglanz, R., Reynolds, A. E., & Wright, A. (1982) · Cell · doi:10.1016/0092-8674(82)90403-2 · Cited by 446
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae
Pan, X. S., Ambler, J., Mehtar, S., & Fisher, L. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2321 · Cited by 437
Emr, an Escherichia coli locus for multidrug resistance.
Lomovskaya, O., & Lewis, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8938 · Cited by 424
Yang, S. W., Burgin, A. B., Huizenga, B. N., Robertson, C. A., Yao, K. C., & Nash, H. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11534 · Cited by 412
Zhao, X., & Drlica, K. (2001) · Clinical Infectious Diseases · doi:10.1086/321841 · Cited by 397
Self-citationLevine, C., Hiasa, H., & Marians, K. J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00126-2 · Cited by 391
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
Yeast Gene for a Tyr-DNA Phosphodiesterase that Repairs Topoisomerase I Complexes
Pouliot, J. J., Yao, K. C., Robertson, C. A., & Nash, H. A. (1999) · Science · doi:10.1126/science.286.5439.552 · Cited by 382
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Pruss, G. J., Manes, S. H., & Drlica, K. (1982) · Cell · doi:10.1016/0092-8674(82)90402-0 · Cited by 374
Self-citationFluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Angulo, F. J., Johnson, K. R., Tauxe, R. V., & Cohen, M. L. (2000) · Microbial Drug Resistance · doi:10.1089/mdr.2000.6.77 · Cited by 343
Butler, J. C., Hofman, J., Cetron, M. S., Elliott, J. A., Facklam, R. R., Breiman, R. F., & Pneumococcal Sentinel Surveillance Working Group (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.986 · Cited by 341
Blondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
Self-citationPfaller, M. A., Jones, R. N., & Beach, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598640 · Cited by 312
Vernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Cohen, S. P., McMurry, L. M., & Levy, S. B. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.12.5416-5422.1988 · Cited by 300
Sahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., & Karlowsky, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1402-1406.2001 · Cited by 294
Wang, H., Dzink-Fox, J. L., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
Dong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Self-citationChromosomes in living Escherichia coli cells are segregated into domains of supercoiling.
Sinden, R. R., & Pettijohn, D. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.224 · Cited by 270
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus
Kaatz, G. W., & Seo, S. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2650 · Cited by 268
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Willmott, C. J., & Maxwell, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.126 · Cited by 252
DNA gyrase action involves the introduction of transient double-strand breaks into DNA.
Mizuuchi, K., Fisher, L. M., O'Dea, M. H., & Gellert, M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.4.1847 · Cited by 247
Krasin, F., & Hutchinson, F. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90120-6 · Cited by 237
Pan, X. S., & Fisher, L. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.471 · Cited by 237
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Giraud, E., Cloeckaert, A., Kerboeuf, D., & Chaslus-Dancla, E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1223-1228.2000 · Cited by 228
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1345 · Cited by 226
Lomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
Multiple Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus
Markham, P. N., Westhaus, E., Klyachko, K., Johnson, M. E., & Neyfakh, A. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2404 · Cited by 218
Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
Chien, S. C., Rogge, M. C., Gisclon, L. G., Curtin, C., Wong, F., Natarajan, J., Williams, R. R., Fowler, C. L., Cheung, W. K., & Chow, A. T. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2256 · Cited by 217
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Self-citationAnalysis of topoisomerase function in bacterial replication fork movement: Use of DNA microarrays
Khodursky, A. B., Peter, B. J., Schmid, M. B., DeRisi, J., Botstein, D., Brown, P. O., & Cozzarelli, N. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9419 · Cited by 211
Zhao, X., & Drlica, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338571 · Cited by 210
Self-citationDNA gyrase on the bacterial chromosome: DNA cleavage induced by oxolinic acid
Snyder, M., & Drlica, K. (1979) · Journal of Molecular Biology · doi:10.1016/0022-2836(79)90077-9 · Cited by 203
Self-citationTakiff, H. E., Cimino, M., Musso, M. C., Weisbrod, T., Martinez, R., Delgado, M. B., Salazar, L., Bloom, B. R., & Jacobs, W. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.362 · Cited by 198
Wetzstein, H.-G., Stadler, M., Tichy, H.-V., Dalhoff, A., & Karl, W. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.4.1556-1563.1999 · Cited by 196
Nalidixic Acid: an Antibacterial Paradox
Crumplin, G. C., & Smith, J. T. (1975) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.8.3.251 · Cited by 194
Sreedharan, S., Oram, M., Jensen, B., Peterson, L. R., & Fisher, L. M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.7260-7262.1990 · Cited by 173
Granizo, J. J. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.767 · Cited by 173
New Uses for New and Old Quinolones and the Challenge of Resistance
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/313677 · Cited by 171
PLASMID-MEDIATED RESISTANCE TO NALIDIXIC ACID IN SHIGELLA DYSENTERIAE TYPE 1
Munshi, M. H., Haider, K., Rahaman, M. M., Sack, D., Ahmed, Z. U., & Morshed, M. G. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90957-3 · Cited by 166
Oethinger, M., Podglajen, I., Kern, W. V., & Levy, S. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2089 · Cited by 164
The Mechanism of Inhibition of Topoisomerase IV by Quinolone Antibacterials
Khodursky, A. B., & Cozzarelli, N. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27668 · Cited by 163
Willmott, C., Critchlow, S. E., Eperon, I. C., & Maxwell, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1586 · Cited by 160
Barnard, F. M., & Maxwell, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1994-2000.2001 · Cited by 160
Gmuender, H., Kuratli, K., Di Padova, K., Gray, C. P., Keck, W., & Evers, S. (2001) · Genome Research · doi:10.1101/gr.157701 · Cited by 160
Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans
Nakashima, M., Uematsu, T., Kosuge, K., Kusajima, H., Ooie, T., Masuda, Y., Ishida, R., & Uchida, H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2635 · Cited by 160
Jones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., Köhrer, K., & Schmitz, F.-J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.462-466.2000 · Cited by 158
Antimicrobial susceptibility and presence of resistance genes in staphylococci from poultry
Aarestrup, F. M., Agersø, Y., Ahrens, P., Jørgensen, J. C. Ø., Madsen, M., & Jensen, L. B. (2000) · Veterinary Microbiology · doi:10.1016/s0378-1135(00)00197-8 · Cited by 155
DNA gyrase binds to the family of prokaryotic repetitive extragenic palindromic sequences.
Yang, Y., & Ames, G. F.-L. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8850 · Cited by 154
Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
Berger, J. M., Fass, D., & Bogden, C. E. (1999) · Nature Structural Biology · doi:10.1038/7556 · Cited by 151
Topoisomerase II drives DNA transport by hydrolyzing one ATP
Baird, C. L., Harkins, T. T., Morris, S. K., & Lindsley, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13685 · Cited by 141
Non-Target Gene Mutations in the Development of Fluoroquinolone Resistance in Escherichia coli
Kern, W. V., Oethinger, M. D., Jellen-Ritter, A., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.814-820.2000 · Cited by 140
Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus
Ubukata, K., Itoh-Yamashita, N., & Konno, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1535 · Cited by 139
Mechanisms of Quinolone Resistance in Clinical Strains of Pseudomonas aeruginosa
Jalal, S., & Wretlind, B. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.257 · Cited by 139
Schmitz, F., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Fluit, A. C., Verhoef, J., Hadding, U., Heinz, H., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1249 · Cited by 137
Hiasa, H., Yousef, D. O., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26424 · Cited by 136
Fournier, B., Zhao, X., Lu, T., Drlica, K., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2160-2165.2000 · Cited by 133
Self-citationGuillemin, I., Jarlier, V., & Cambau, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2084 · Cited by 132
Dong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
Self-citationInstruments of microbial warfare: Bacteriocin synthesis, toxicity and immunity
Baba, T., & Schneewind, O. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01196-7 · Cited by 123
Bast, D. J., Low, D. E., Duncan, C. L., Kilburn, L., Mandell, L. A., Davidson, R., & de Azavedo, J. C. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3049-3054.2000 · Cited by 122
Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Mauriz, Y., & Kahn, J. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1037-1042.2001 · Cited by 121
Bennish, M. L., Salam, M. A., Hossain, M. A., Myaux, J., Khan, E. H., Chakraborty, J., Henry, F. J., & Ronsmans, C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.5.1055 · Cited by 120
Pan, X.-S., & Fisher, L. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1129 · Cited by 119
Montero, C. I., Mateu, G., Rodríguez, R., & Takiff, H. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 117
Two Distinct Modes of Strand Unlinking during θ-Type DNA Replication
Hiasa, H., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21529 · Cited by 116
Alovero, F. L., Pan, X.-S., Morris, J. E., Manzo, R. H., & Fisher, L. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.320-325.2000 · Cited by 116
A Nosocomial Outbreak of Fluoroquinolone‐ResistantStreptococcus pneumoniae
Weiss, K., Restieri, C., Gauthier, R., Laverdière, M., McGeer, A., Davidson, R., Kilburn, L., Bast, D. J., de Azavedo, J., & Low, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/322658 · Cited by 116
Markham, P. N., & Neyfakh, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2673 · Cited by 111
Mechanisms of quinolone resistance in Salmonella
Cloeckaert, A., & Chaslus-Dancla, E. (2001) · Veterinary Research · doi:10.1051/vetres:2001105 · Cited by 109
Schmitz, F., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Klootwijk, M., Verhoef, J., Fluit, A., Heinz, H. P., Köhrer, K., et al. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.4.481 · Cited by 108
Maira‐Litrán, T., Allison, D., & Gilbert, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.789 · Cited by 105
Chemistry and Mechanisms of Action of the Quinolone Antibacterials
Smith, J. T., & Lewin, C. S. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-059515-0.50006-8 · Cited by 103
Schentag, J. J. (1999) · Journal of Chemotherapy · doi:10.1179/joc.1999.11.6.426 · Cited by 100
Markham, P. N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.988 · Cited by 97
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Beyer, R., Pestova, E. V., Millichap, J. G., Stosor, V., Noskin, G. A., & Peterson, L. R. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.798-801.2000 · Cited by 94
Kays, M. B., Smith, D. W., Wack, M. F., & Denys, G. A. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.5.395.33185 · Cited by 93
Ferrándiz, M.-J., Fenoll, A., Liñares, J., & de la Campa, A. G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.840-847.2000 · Cited by 91
DNA Cleavage Is Not Required for the Binding of Quinolone Drugs to the DNA Gyrase−DNA Complex
Critchlow, S. E., & Maxwell, A. (1996) · Biochemistry · doi:10.1021/bi9603175 · Cited by 89
Goldman, J. D., White, D. G., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1266 · Cited by 89
Levofloxacin Failure in a Patient with Pneumococcal Pneumonia
Empey, P. E., Jennings, H. R., Thornton, A., Rapp, R. P., & Evans, M. E. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.10229 · Cited by 87
4-Quinolones and the SOS response
Lewin, C. S., Howard, B. M. A., Ratcliff, N. T., & Smith, J. T. (1989) · Journal of Medical Microbiology · doi:10.1099/00222615-29-2-139 · Cited by 87
Incidence of mutator strains in Escherichia coli and coliforms in nature
Gross, M. D., & Siegel, E. C. (1981) · Mutation Research Letters · doi:10.1016/0165-7992(81)90081-6 · Cited by 86
Gyrase and Topo IV modulate chromosome domain size in vivo
Stączek, P., & Higgins, N. P. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01025.x · Cited by 86
The Interaction of Drugs with DNA Gyrase: A Model for the Molecular Basis of Quinolone Action
Heddle, J. G., Barnard, F. M., Wentzell, L. M., & Maxwell, A. (2000) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770008033048 · Cited by 83
Wentzell, L. M., & Maxwell, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4266 · Cited by 83
Heaton, V. J., Ambler, J. E., & Fisher, L. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3112-3117.2000 · Cited by 82
Garg, P., Sinha, S., Chakraborty, R., Bhattacharya, S., Nair, G. B., Ramamurthy, T., & Takeda, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1605-1606.2001 · Cited by 81
Takenouchi, T., Tabata, F., Iwata, Y., Hanzawa, H., Sugawara, M., & Ohya, S. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1835 · Cited by 79
McDaniel, L. S., Rogers, L., & Hill, W. E. (1978) · Journal of Bacteriology · doi:10.1128/jb.134.3.1195-1198.1978 · Cited by 76
Topoisomerase IV Catalysis and the Mechanism of Quinolone Action
Anderson, V. E., Gootz, T. D., & Osheroff, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17879 · Cited by 75
Mamber, S. W., Kolek, B., Brookshire, K. W., BONNER, D. P., & Fung-Tomc, J. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.213 · Cited by 74
Sahm, D. F., Peterson, D. E., Critchley, I. A., & Thornsberry, C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2521-2524.2000 · Cited by 73
Pan, X.-S., Yagüe, G., & Fisher, L. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3140-3147.2001 · Cited by 70
Boccard, F., & Prentki, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06195.x · Cited by 66
Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage
Williams, N. L., Howells, A. J., & Maxwell, A. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4468 · Cited by 65
OBSERVATIONS ON TWO TYPES OF GENETIC INSTABILITY IN ESCHERICHIA COLI
Jyssum, K. (1960) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1960.tb04747.x · Cited by 62
Piddock, L. J. V., & Walters, R. N. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.4.819 · Cited by 62
Goldsmith, C. E., Moore, J. E., Murphy, P. G., & Ambler, J. E. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.3.420 · Cited by 59
Espéli, O., & Boccard, F. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.6121983.x · Cited by 59
Structural and functional diversity among bacterial interspersed mosaic elements (BIMEs)
Bachellier‐Bassi, S., Saurin, W., Perrin, D. M., Hofnung, M. J., & Gilson, É. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00995.x · Cited by 58
Jones, M. E., Schmitz, F., Fluit, A. C., Acar, J. F., Gupta, R., & Verhoef, J. (1999) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050308 · Cited by 55
DNA gyrase complex with DNA: determinants for site‐specific DNA breakage.
Fisher, L. M., Barot, H. A., & Cullen, M. E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04375.x · Cited by 55
İnce, D., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3344-3350.2000 · Cited by 53
Rastogi, N., Ross, B. C., Dwyer, B., Goh, K. S., Clavel-Sérès, S., Jeantils, V., & Cruaud, P. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01962370 · Cited by 50
DNA gyrase on the bacterial chromosome
Franco, R. J., & Drlica, K. (1988) · Journal of Molecular Biology · doi:10.1016/0022-2836(88)90449-4 · Cited by 49
Self-citationSchmitz, F., Fluit, A. C., Brisse, S., Verhoef, J., Köhrer, K., & Milatović, D. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01400.x · Cited by 48
Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents
Gradelski, E., Kolek, B., BONNER, D. P., Valera, L., Minassian, B., & Fung-Tomc, J. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00317-4 · Cited by 44
Huang, W. M., Libbey, J. L., van der Hoeven, P., & Yu, S. X. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4652 · Cited by 44
Very Low Cefotaxime Concentrations Select for Hypermutable Streptococcus pneumoniae Populations
Negri, M.-C., Morosini, M.-I., Baquero, M.-R., del Campo, R., Blázquez, J., & Baquero, F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.528-530.2002 · Cited by 40
Resistance to Quinolones in Gram-Negative Microorganisms: Mechanisms and Prevention
Baquero, F. (1990) · European Urology · doi:10.1159/000464084 · Cited by 40
Richardson, D. C., Bast, D. J., McGeer, A., & Low, D. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1911-1914.2001 · Cited by 38
García-Rey, C., Aguilar, L., Baquero, F., & Spanish Surveillance Group for Respiratory Pathogens (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3481-3482.2000 · Cited by 38
Anderson, V. E., Zaniewski, R. P., Kaczmarek, F. S., Gootz, T. D., & Osheroff, N. (2000) · Biochemistry · doi:10.1021/bi992302n · Cited by 37
Vatopoulos, A. C., Kalapothaki, Greek Network, Resistance, F. T. S. O. A., & Legakis, N. J. (1999) · Emerging infectious diseases · doi:10.3201/eid0503.990325 · Cited by 35
Guillemin, I., Sougakoff, W., Cambau, E., et al. (1999) · Microbiology · doi:10.1099/00221287-145-9-2527 · Cited by 35
Hong, G., & Kreuzer, K. N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.594-603.2000 · Cited by 35
Fogarty, C. M., Greenberg, R. N., Dunbar, L. M., Player, R., Marrie, T. J., Kojak, C., Morgan, N., & Williams, R. R. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80047-3 · Cited by 33
Bast, D. J., de Azavedo, J. C. S., Tam, T. Y., Kilburn, L., Duncan, C. L., Mandell, L. A., Davidson, R., & Low, D. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2631-2634.2001 · Cited by 29
Jones, R. N., Pfaller, M. A., & Stilwell, M. G. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00233-9 · Cited by 29
Immunogold localization of GyrA and GyrB proteins in Escherichia coli
Thornton, M., Armitage, M., Maxwell, A., Dosanjh, B., Howells, A. J., Norris, V., & Sigee, D. C. (1994) · Microbiology · doi:10.1099/13500872-140-9-2371 · Cited by 26
The form of chromosomal DNA molecules in bacterial cells
Bendich, A. J. (2001) · Biochimie · doi:10.1016/s0300-9084(00)01209-8 · Cited by 26
DNA Topoisomerase-Mediated Illegitimate Recombination
Ikeda, H. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60544-x · Cited by 26
Jones, R. N., & Pfaller, M. A. (2001) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00229-2 · Cited by 22
Cited by
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Metadata
- Authors
- Drlica, K., & Malik, M.
- Venue
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2003-01-01
- Volume
- 3
- Issue
- 3
- Pages
- 249-282
- ISSN
- 1568-0266 (ISSN-L)
- OpenAlex
- W2118813171
- Cited by
- 317
- References
- 158
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.